The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.